178 related articles for article (PubMed ID: 22956286)
1. Expression of matrix macromolecules and functional properties of EGF-responsive colon cancer cells are inhibited by panitumumab.
Gialeli Ch; Theocharis AD; Kletsas D; Tzanakakis GN; Karamanos NK
Invest New Drugs; 2013 Jun; 31(3):516-24. PubMed ID: 22956286
[TBL] [Abstract][Full Text] [Related]
2. EGFR and HER2 exert distinct roles on colon cancer cell functional properties and expression of matrix macromolecules.
Ellina MI; Bouris P; Aletras AJ; Theocharis AD; Kletsas D; Karamanos NK
Biochim Biophys Acta; 2014 Aug; 1840(8):2651-61. PubMed ID: 24792576
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of EGF/EGFR activation with naphtho[1,2-b]furan-4,5-dione blocks migration and invasion of MDA-MB-231 cells.
Hsieh CY; Tsai PC; Tseng CH; Chen YL; Chang LS; Lin SR
Toxicol In Vitro; 2013 Feb; 27(1):1-10. PubMed ID: 23064031
[TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor modulates prostate cancer cell invasiveness regulating urokinase-type plasminogen activator activity. EGF-receptor inhibition may prevent tumor cell dissemination.
Festuccia C; Angelucci A; Gravina GL; Biordi L; Millimaggi D; Muzi P; Vicentini C; Bologna M
Thromb Haemost; 2005 May; 93(5):964-75. PubMed ID: 15886816
[TBL] [Abstract][Full Text] [Related]
5. EGFR signaling downstream of EGF regulates migration, invasion, and MMP secretion of immortalized cells derived from human ameloblastoma.
da Rosa MR; Falcão AS; Fuzii HT; da Silva Kataoka MS; Ribeiro AL; Boccardo E; de Siqueira AS; Jaeger RG; de Jesus Viana Pinheiro J; de Melo Alves Júnior S
Tumour Biol; 2014 Nov; 35(11):11107-20. PubMed ID: 25099616
[TBL] [Abstract][Full Text] [Related]
6. EGF receptor transactivation by urokinase receptor stimulus through a mechanism involving Src and matrix metalloproteinases.
Guerrero J; Santibañez JF; González A; Martínez J
Exp Cell Res; 2004 Jan; 292(1):201-8. PubMed ID: 14720519
[TBL] [Abstract][Full Text] [Related]
7. Docosahexaenoic Acid Downregulates EGF-Induced Urokinase Plasminogen Activator and Matrix Metalloproteinase 9 Expression by Inactivating EGFR/ErbB2 Signaling in SK-BR3 Breast Cancer Cells.
Li CC; Yao HT; Cheng FJ; Hsieh YH; Lu CY; Wu CC; Liu KL; Chang JW
Nutr Cancer; 2015; 67(5):771-82. PubMed ID: 25970488
[TBL] [Abstract][Full Text] [Related]
8. Activity of panitumumab alone or with chemotherapy in non-small cell lung carcinoma cell lines expressing mutant epidermal growth factor receptor.
Freeman DJ; Bush T; Ogbagabriel S; Belmontes B; Juan T; Plewa C; Van G; Johnson C; Radinsky R
Mol Cancer Ther; 2009 Jun; 8(6):1536-46. PubMed ID: 19509246
[TBL] [Abstract][Full Text] [Related]
9. Adhesion, actin cytoskeleton organisation and the spreading of colon adenocarcinoma cells induced by EGF are mediated by alpha2beta1 integrin low clustering through focal adhesion kinase.
Pichard V; Honoré S; Kovacic H; Li C; Prevôt C; Briand C; Rognoni JB
Histochem Cell Biol; 2001 Oct; 116(4):337-48. PubMed ID: 11702192
[TBL] [Abstract][Full Text] [Related]
10. Combined inhibition of EMMPRIN and epidermal growth factor receptor prevents the growth and migration of head and neck squamous cell carcinoma cells.
Suzuki S; Ishikawa K
Int J Oncol; 2014 Mar; 44(3):912-7. PubMed ID: 24379084
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor stimulates urokinase-type plasminogen activator expression in human gingival fibroblasts. Possible modulation by genistein and curcumin.
Smith PC; Santibañez JF; Morales JP; Martinez J
J Periodontal Res; 2004 Dec; 39(6):380-7. PubMed ID: 15491342
[TBL] [Abstract][Full Text] [Related]
12. Curcumin attenuates hyperglycemia-driven EGF-induced invasive and migratory abilities of pancreatic cancer via suppression of the ERK and AKT pathways.
Li W; Wang Z; Xiao X; Han L; Wu Z; Ma Q; Cao L
Oncol Rep; 2019 Jan; 41(1):650-658. PubMed ID: 30542713
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor receptor-mediated regulation of urokinase plasminogen activator expression and glioblastoma invasion via C-SRC/MAPK/AP-1 signaling pathways.
Amos S; Redpath GT; Dipierro CG; Carpenter JE; Hussaini IM
J Neuropathol Exp Neurol; 2010 Jun; 69(6):582-92. PubMed ID: 20467333
[TBL] [Abstract][Full Text] [Related]
14. Urokinase-induced smooth muscle cell responses require distinct signaling pathways: a role for the epidermal growth factor receptor.
Nicholl SM; Roztocil E; Davies MG
J Vasc Surg; 2005 Apr; 41(4):672-81. PubMed ID: 15874933
[TBL] [Abstract][Full Text] [Related]
15. Differential modulation of proliferation, matrix metalloproteinase expression and invasion of human head and neck squamous carcinoma cells by c-erbB ligands.
O-charoenrat P; Rhys-Evans P; Court WJ; Box GM; Eccles SA
Clin Exp Metastasis; 1999; 17(7):631-9. PubMed ID: 10845563
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase-7-catalyzed release of HB-EGF mediates deoxycholyltaurine-induced proliferation of a human colon cancer cell line.
Cheng K; Xie G; Raufman JP
Biochem Pharmacol; 2007 Apr; 73(7):1001-12. PubMed ID: 17222808
[TBL] [Abstract][Full Text] [Related]
17. Urokinase receptor primes cells to proliferate in response to epidermal growth factor.
Jo M; Thomas KS; Takimoto S; Gaultier A; Hsieh EH; Lester RD; Gonias SL
Oncogene; 2007 Apr; 26(18):2585-94. PubMed ID: 17043637
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor receptor-mediated membrane type 1 matrix metalloproteinase endocytosis regulates the transition between invasive versus expansive growth of ovarian carcinoma cells in three-dimensional collagen.
Moss NM; Liu Y; Johnson JJ; Debiase P; Jones J; Hudson LG; Munshi HG; Stack MS
Mol Cancer Res; 2009 Jun; 7(6):809-20. PubMed ID: 19509114
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor receptor-mediated regulation of matrix metalloproteinase-2 and matrix metalloproteinase-9 in MCF-7 breast cancer cells.
Majumder A; Ray S; Banerji A
Mol Cell Biochem; 2019 Feb; 452(1-2):111-121. PubMed ID: 30074136
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor receptor (EGFR)-related protein inhibits multiple members of the EGFR family in colon and breast cancer cells.
Xu H; Yu Y; Marciniak D; Rishi AK; Sarkar FH; Kucuk O; Majumdar AP
Mol Cancer Ther; 2005 Mar; 4(3):435-42. PubMed ID: 15767552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
